
Governor’s plan: $230 million for behavioral health, funding for 30 mobile crisis teams
Virginia Governor Glenn Youngkin is proposing $230 million in new funding for behavioral health in his upcoming budget.
Virginia Governor Glenn Youngkin is proposing $230 million in new funding for behavioral health in his upcoming budget.
In recognition of National Recovery Month, the U.S. Congress Joint Economic Committee released a new analysis that finds the opioid epidemic cost the United States a record of nearly $1.5 trillion in 2020.
Among Medicaid enrollees with opioid use disorder, having a follow-up visit seven days after an emergency department visit lowers their risk of fatal or nonfatal overdoses within six months.
Virginia localities and stakeholders have now agreed to the $26 billion settlement framework negotiated against opioid distributors and Johnson & Johnson.
The Opioid Abatement Authority has received the first funds secured through Attorney General Mark R. Herring’s ongoing work to hold accountable the drug manufacturers, distributors, and others that helped create and prolong the opioid crisis.
Virginia is expected to receive more than half a billion dollars from opioid distributors McKesson, AmerisourceBergen and Cardinal, and opioid manufacturer Johnson & Johnson.
The Treasury Department today released guidance on acceptable uses of American Rescue Plan funds — including to combat the substance abuse epidemic in communities across the country.
A bipartisan effort is calling on the Treasury Department to allow states to use American Rescue Plan funding to combat increases in drug overdose deaths witnessed during the COVID-19 pandemic.
Legislation directing funds from lawsuits against drug manufacturers and distributors to go toward opioid abuse prevention, treatment and recovery is headed to the governor’s desk to be signed into law.
McKinsey & Company has agreed to a $573 million settlement to resolve investigations into the consulting firm’s role in working for opioid companies, helping those companies promote their drugs, and profiting from the opioid epidemic.